Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.320
-0.080 (-5.71%)
At close: Aug 13, 2025, 4:00 PM
1.350
+0.030 (2.27%)
After-hours: Aug 13, 2025, 6:40 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $5.57 million as of August 13, 2025. Its market cap has increased by 57.03% in one year.
Market Cap
5.57M
Enterprise Value
6.28M
1-Year Change
57.03%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $5.57M, a decrease of -86.47%. That is a compound annual growth rate of -42.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.91M | 50.54% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |